Novartis launches largest diabetes prevention trial to date
11-Sep-2001 -
Basel, 10 September 2001 – Novartis today announced the launch of NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research), the largest-ever diabetes prevention clinical trial to date, which aims to determine whether long-term administration of Starlix® (nateglinide) ...
cardiovascular diseases
clinical trials
food
+4